Key Drivers
- Robust Margins
- Strong Liquidity
- Low Debt
AIAI Summary
CorVel is a cash-rich, high-return claims-services compounder, but at 27–32x earnings the actionable thesis is to own only if sustained double-digit growth and margin expansion remain evident, as even modest normalization could trigger a sharp de-rating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Robust Margins
- •Strong Liquidity
- •Low Debt
CRVL combines strong profitability, cash generation, and low debt with a premium valuation, making it attractive operationally but dependent on continued growth for upside.
Price Behavior
Key Price Behavior Insights:
- •Constructive range
- •Rally stalled
- •Support pivotal
CRVL is range-bound with a constructive bias; hold above $69.20–$69.40 for upside toward $71.20–$72.20, while a break below support weakens the setup.
Roughly 6% rebound from the early-September trough before profit-taking
Sentiment & News
Key News Insights:
- •Peer comparison
- •No clear winner
- •No catalyst
CorVel was compared with Wellgistics Health on financial and operational metrics, with no disclosed winner or company-specific catalyst.
The analysis is neutral for CRVL, offering benchmarking context rather than a material near-term impact
Similar Companies in Financial Services
Other companies in the same sector with AI ratings